Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3045-3052
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3045
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3045
Table 3 Comparison of T-cell subsets before and after treatment (mean ± SD)
| Indicators | Time | Observation group (n = 40) | Control group (n = 40) | t | P value |
| CD4+ (%) | Before treatment | 12.15 ± 2.41 | 11.63 ± 2.32 | 0.983 | 0.329 |
| After treatment | 9.62 ± 2.21 | 8.86 ± 1.84 | 1.671 | 0.099 | |
| CD8+ (%) | Before treatment | 3.41 ± 0.66 | 3.33 ± 0.64 | 0.550 | 0.584 |
| After treatment | 4.45 ± 0.76a | 5.17 ± 0.92a | 3.816 | 0.000 | |
| CD4+/CD8+ | Before treatment | 3.52 ± 0.82 | 3.46 ± 0.75 | 0.341 | 0.734 |
| After treatment | 2.54 ± 0.55a | 1.97 ± 0.47a | 4.983 | 0.000 |
- Citation: Yin Y, Yao Y, Li YJ, Zhao LL, Zhang Q. Effects of Tongluo Jiedu prescription on immune function and oxidative stress in patients with oral cancer. World J Clin Cases 2024; 12(17): 3045-3052
- URL: https://www.wjgnet.com/2307-8960/full/v12/i17/3045.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i17.3045